- Home
- NATR vs THRD Comparison
NATR vs THRD Comparison
Compare NATR & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- THRD
- Stock Information
- Founded
- NATR 1972
- THRD 2019
- Country
- NATR United States
- THRD United States
- Employees
- NATR N/A
- THRD N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- NATR Health Care
- THRD Health Care
- Exchange
- NATR Nasdaq
- THRD Nasdaq
- Market Cap
- NATR 295.8M
- THRD 238.7M
- IPO Year
- NATR N/A
- THRD 2022
- Fundamental
- Price
- NATR $14.71
- THRD $5.41
- Analyst Decision
- NATR Strong Buy
- THRD Hold
- Analyst Count
- NATR 2
- THRD 3
- Target Price
- NATR $18.50
- THRD $5.00
- AVG Volume (30 Days)
- NATR 96.0K
- THRD 211.0K
- Earning Date
- NATR 07-31-2025
- THRD 08-07-2025
- Dividend Yield
- NATR N/A
- THRD N/A
- EPS Growth
- NATR N/A
- THRD N/A
- EPS
- NATR 0.53
- THRD N/A
- Revenue
- NATR $456,619,000.00
- THRD N/A
- Revenue This Year
- NATR $3.08
- THRD N/A
- Revenue Next Year
- NATR $2.41
- THRD N/A
- P/E Ratio
- NATR $27.90
- THRD N/A
- Revenue Growth
- NATR 2.00
- THRD N/A
- 52 Week Low
- NATR $10.81
- THRD $3.18
- 52 Week High
- NATR $18.06
- THRD $16.02
- Technical
- Relative Strength Index (RSI)
- NATR 46.10
- THRD 51.37
- Support Level
- NATR $14.30
- THRD $5.40
- Resistance Level
- NATR $15.23
- THRD $5.47
- Average True Range (ATR)
- NATR 0.48
- THRD 0.05
- MACD
- NATR -0.10
- THRD -0.01
- Stochastic Oscillator
- NATR 21.24
- THRD 8.00
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.